ESTIMATED ANNUAL MORBIDITY IN THE USA
By staff reporters
***
***
Filed under: Drugs and Pharma | Tagged: corona, Covid-19, pandemic | 1 Comment »
ESTIMATED ANNUAL MORBIDITY IN THE USA
By staff reporters
***
***
Filed under: Drugs and Pharma | Tagged: corona, Covid-19, pandemic | 1 Comment »
2021 Annual [Faux] Registration Letter
By Staff reporters
Below is a copy of a letter that some colleagues and clients have been receiving and asking us about.
This letter is not from a government agency and is not real. See the sections highlighted in yellow.
Please do not pay anything to this company. Thanks!
We recently received this notice.
It is untrue.
***
***
Filed under: Quality Initiatives, Risk Management | Tagged: faux business | Leave a comment »
Markets 101: How to Read Stock Indexes and Securities
By Alex Hickey of Morning Brew
Everything you need to know about the 3 top U.S. equities indexes plus gold, oil, and Treasury notes
***
LINK:
**

Filed under: Experts Invited, Investing | Tagged: Alex Hickey, Investing, Morning Brew, stock markets | Leave a comment »
[You should read this]
Filed under: "Ask-an-Advisor", Information Technology | Tagged: Are Dentists Satisfied with their EDRs?, Darrell K. Pruitt DDS, EHRs | 1 Comment »
Comparison with Commonalities
By Staff reporters
***
Filed under: Drugs and Pharma | Tagged: BioNet, corona vaccine, corona virus, Moderna | 1 Comment »
Defense versus Offense
***
***
Filed under: Drugs and Pharma, Health Economics, iMBA, Inc. | Tagged: corona pandemic | 2 Comments »
COVID-19 and Long Term Care Facilities
***
***
Filed under: Health Insurance | Tagged: Covid-19, LTC insurance, pandemic | Leave a comment »
WHAT’S IN IT – AND WHY?
By Un-Biased Science
***
Filed under: Drugs and Pharma | Tagged: Covid vaccine, UnBiased Science | 3 Comments »
Not Inflation Protected
By Federal Register
***
***
Filed under: Health Economics, Health Insurance, Health Law & Policy, iMBA, Inc. | Tagged: federal register, Physician Reimbursement | Leave a comment »
The Future of Digital Health***
***
|
| Open this article on LinkedIn to see what people are saying about this topic. Open on LinkedIn |
|
|
Filed under: Events-Planner, Information Technology | Tagged: Bertalan Meskó, Digital Health, MD, PhD | Leave a comment »
THE BUSINESS OF MEDICAL PRACTICE AND HOSPITAL MANAGEMENT
BUSINESS, FINANCE, INVESTING AND INSURANCE TEXTS FOR DOCTORS:
1 – https://lnkd.in/ebWtzGg
2 – https://lnkd.in/ezkQMfR
3 – https://lnkd.in/ewJPTJs
HOSPITAL MANAGEMENT & BUSINESS TEXTS FOR PHYSICIANS AND CXOs:
1 – https://lnkd.in/eEf-xEH 2 – https://lnkd.in/e2ZmewQ
“DICTIONARY OF TERMS FOR THE BUSINESS OF MEDICINE”
DHEF: https://lnkd.in/dqdbWM9
DHIMC: https://lnkd.in/e9AmEhd
DHITS: https://lnkd.in/eWx3WjZ
MORE: https://lnkd.in/eVGcji5
THANK YOU
***
***
Filed under: Financial Planning, Glossary Terms, Health Economics, Health Insurance, Health Law & Policy, iMBA, Inc. | Tagged: “Investment Planning for Financial Professionals” | Leave a comment »
COVID-19 [NIHCM]
By staff reporters
***
***
Filed under: Drugs and Pharma, Glossary Terms, Health Economics, Health Insurance | Tagged: corona disparity, covid racism | 1 Comment »
Hypercytokinemia and Covid-19
By staff reporters
A cytokine storm, also called hypercytokinemia, is a physiological reaction in humans and other animals in which the innate immune system causes an uncontrolled and excessive release of pro-inflammatory signaling molecules called cytokines.
Normally, cytokines are part of the body’s immune response to infection, but their sudden release in large quantities can cause multisystem organ failure and death.
Cytokine storms can be caused by a number of infectious and non-infectious etiologies, especially viral respiratory infections such as H5N1 influenza, SARS-CoV-1, and SARS-CoV-2. Other causative agents include the Epstein-Barr virus, cytomegalovirus, and group A streptococcus, and non-infectious conditions such as graft-versus-host disease.
***
Filed under: Drugs and Pharma, LifeStyle | Tagged: Cytokine Storm, hypercytokinemia, roid rage, steroids | 1 Comment »
Filed under: iMBA, Inc., Research & Development | Tagged: Marcinko | Leave a comment »
UPDATE
By staff reporters
***
***
Filed under: Drugs and Pharma | Tagged: 23 Potential COVID-19 Drugs, corona, corona test accuracy, pandemic | 1 Comment »
EXACTLY WHAT IS THE PRODUCER PRICE INDEX [PPI]?
Courtesy: https://lnkd.in/eBf-4vY
ECONOMICS INFORMATION FOR PHYSICIAN COLLEAGUES
Web: https://lnkd.in/eVGcji5
DEFINITION: The PPI is a group of indexes that measure the change, over time, in the prices received by domestic producers of goods and services. It measures price changes from the perspective of the seller rather than the consumer, as with the CPI. The CPI would include imported goods, while the PPI is relevant to U.S. producers, and therefore would not include imports.
The PPI measures over 10,000 products and services. It reports the price changes prior to the retail level. This information is useful to the government in formulating fiscal and monetary policies. The data gathered from the PPI is often used in escalating purchase and sales contracts. That is the dollar amount to be paid at some time in the future.
NOTE: Long-term managed medical care contracts of the future will seek escalation clauses for increases in prices.
DHEF: https://lnkd.in/dqdbWM9
BUSINESS, FINANCE, INVESTING AND INSURANCE TEXTS FOR DOCTORS:
1 – https://lnkd.in/ebWtzGg
2 – https://lnkd.in/ezkQMfR
3 – https://lnkd.in/ewJPTJs
Thank You
***
Filed under: Financial Planning, iMBA, Inc. | Tagged: PPI, producer, Producer Price Index | Leave a comment »
***
Filed under: Health Economics, Health Insurance, iMBA, Inc. | Tagged: ACOs, CMS, Value-Based care, VBID | Leave a comment »